MCL1 and neoplasm: After using RNA interference to downregulate MCL-1 in tumour cells, the sensitivity of the cells to ABT-737 was increased.[16–19] The structure of venetoclax is similar to that of ABT-737; thus, venetoclax resistance may also be related to the level of MCL-1 in tumour cells.